Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig T Jordan

Showing results (21-30 of 164) with videos related to

Pageof 17
Sort By:
Expert Opinion on Biological Therapy|August 27, 2005
Feverfew: weeding out the root of leukaemiaMonica L Guzman, Craig T Jordan
Cancer Cell|April 7, 2009
Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biologyMonica L Guzman, Craig T Jordan
The New England Journal of Medicine|September 23, 2006
Cancer stem cellsCraig T Jordan, Monica L Guzman, Mark Noble
Cell Stem Cell|March 5, 2021
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid TumorsCourtney L Jones, Anagha Inguva, Craig T Jordan
Electronic Journal of Statistics|May 3, 2016
A test of homogeneity for age-dependent branching processes with immigrationOllivier Hyrien, Nikolay M Yanev, Craig T Jordan
Hematology. American Society of Hematology. Education Program|November 25, 2004
The molecular basis of leukemiaD Gary Gilliland, Craig T Jordan, Carolyn A Felix
Stem Cells (Dayton, Ohio)|July 28, 2004
The hematopoietic stem cell in myelodysplasiaJane L Liesveld, Craig T Jordan, Gordon L Phillips
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latencyFelicia D Goodrum, Craig T Jordan, Kevin High, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2011
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in cultureShama Nasim, Monica L Guzman, Craig T Jordan, et al.
ACS Chemical Biology|November 12, 2013
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalizationJoshua N Kolev, Kristen M O'Dwyer, Craig T Jordan, et al.
Pageof 17

Showing results (21-30 of 164) with videos related to

Sort By:
Pageof 17
Expert Opinion on Biological Therapy|August 27, 2005
Feverfew: weeding out the root of leukaemiaMonica L Guzman, Craig T Jordan
Cancer Cell|April 7, 2009
Lessons learned from the study of JunB: new insights for normal and leukemia stem cell biologyMonica L Guzman, Craig T Jordan
The New England Journal of Medicine|September 23, 2006
Cancer stem cellsCraig T Jordan, Monica L Guzman, Mark Noble
Cell Stem Cell|March 5, 2021
Targeting Energy Metabolism in Cancer Stem Cells: Progress and Challenges in Leukemia and Solid TumorsCourtney L Jones, Anagha Inguva, Craig T Jordan
Electronic Journal of Statistics|May 3, 2016
A test of homogeneity for age-dependent branching processes with immigrationOllivier Hyrien, Nikolay M Yanev, Craig T Jordan
Hematology. American Society of Hematology. Education Program|November 25, 2004
The molecular basis of leukemiaD Gary Gilliland, Craig T Jordan, Carolyn A Felix
Stem Cells (Dayton, Ohio)|July 28, 2004
The hematopoietic stem cell in myelodysplasiaJane L Liesveld, Craig T Jordan, Gordon L Phillips
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latencyFelicia D Goodrum, Craig T Jordan, Kevin High, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2011
Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in cultureShama Nasim, Monica L Guzman, Craig T Jordan, et al.
ACS Chemical Biology|November 12, 2013
Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalizationJoshua N Kolev, Kristen M O'Dwyer, Craig T Jordan, et al.
Pageof 17